MAX FLEX Trademark

Trademark Overview

On Thursday, February 10, 2022, a trademark application was filed for MAX FLEX with the United States Patent and Trademark Office. The USPTO has given the MAX FLEX trademark a serial number of 97262302. The federal status of this trademark filing is NOT AVAILABLE as of Thursday, December 11, 2025. This trademark is owned by Ema Pharma, Inc.. The MAX FLEX trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for Treatment of Joint Diseases; Pharmaceutical products for the treatment of joint disease
max flex

General Information

Serial Number97262302
Word MarkMAX FLEX
Filing DateThursday, February 10, 2022
Status610 - NOT AVAILABLE
Status DateThursday, December 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of Max Flex written in stylized fonts.
Goods and ServicesMedicinal preparations for Treatment of Joint Diseases; Pharmaceutical products for the treatment of joint disease
Indication of Colors claimedThe color(s) red, blue, is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeX - NOT AVAILABLE
Class Status DateThursday, December 11, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEma Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAstoria, NY 11106

Trademark Events

Event DateEvent Description
Monday, February 14, 2022NEW APPLICATION ENTERED
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 17, 2025SHOW CAUSE ORDER
Wednesday, September 17, 2025SUSPENDED PENDING ADMINISTRATIVE REVIEW
Wednesday, September 17, 2025NOTICE OF SUSPENSION EMAILED - PENDING SCO
Thursday, December 11, 2025ORDER FOR SANCTIONS
Thursday, December 11, 2025ORDER FOR SANCTIONS - NOTICE EMAILED
Thursday, December 11, 2025TERMINATED AFTER SANCTIONS
Thursday, December 11, 2025NOTICE OF TERMINATION – EMAILED

Related Keywords

flex treatment joint products disease pharmaceutical diseases medicinal preparations